Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Pharmacokinetics of NVP-1203 in Healthy Adults
NCT02289404Phase 1Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Jan 2019
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aceclofenac and eperisone in acute low back pain and Muscle spasm (2 arms), sponsored by NVP Healthcare Co., Ltd. Primary endpoints: Maximum Plasma Concentration and Area Under the Concentration-Time Curve from time zero to last quantifiable concentration. Started Jan 2019; status: completed.
02
Drugs
aceclofenaceperisone
03
Conditions
acute low back painMuscle spasm
Beyond the preview
Go deeper on NCT02289404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289404.